We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-13.61%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$2.03B
AUM Growth
-$570M
Cap. Flow
-$189M
Cap. Flow %
-9.31%
Top 10 Hldgs %
6.46%
Holding
2,297
New
383
Increased
673
Reduced
638
Closed
591

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$15.4M
2
ORCL icon
Oracle
ORCL
+$13.9M
3
ADSK icon
Autodesk
ADSK
+$11.6M
4
UNP icon
Union Pacific
UNP
+$11.4M
5
RTN
Raytheon Company
RTN
+$11.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.57%
2 Consumer Discretionary 14.52%
3 Industrials 10.07%
4 Technology 10.02%
5 Financials 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STX icon
26
Seagate
STX
$193B
$6.39M 0.31%
142,718
-25,991
-15% -$1.26M
MS icon
27
Morgan Stanley
MS
$330B
$6.35M 0.31%
201,542
+176,002
+689% +$6.41M
CVS icon
28
CVS Health
CVS
$134B
$6.33M 0.31%
+65,594
New +$6.9M
MHFI
29
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$6.21M 0.31%
71,748
+31,241
+77% +$3.07M
SLB icon
30
SLB Ltd
SLB
$72.6B
$6.01M 0.3%
87,126
+73,246
+528% +$5.8M
MJN
31
DELISTED
Mead Johnson Nutrition Company
MJN
$5.75M 0.28%
81,736
+71,374
+689% +$5.87M
UTHR icon
32
United Therapeutics
UTHR
$26.2B
$5.7M 0.28%
43,435
-2,755
-6% -$442K
MRK icon
33
Merck
MRK
$321B
$5.6M 0.28%
118,815
+61,072
+106% +$3.24M
AAPL icon
34
Apple
AAPL
$4.9T
$5.55M 0.27%
+201,412
New +$5.91M
STJ
35
DELISTED
St Jude Medical
STJ
$5.36M 0.26%
85,024
+62,962
+285% +$4.49M
THC icon
36
Tenet Healthcare
THC
$21.8B
$5.32M 0.26%
144,187
+107,197
+290% +$5.54M
NEE icon
37
NextEra Energy
NEE
$183B
$5.3M 0.26%
+217,360
New +$5.53M
BABA icon
38
Alibaba
BABA
$279B
$5.27M 0.26%
89,344
-33,431
-27% -$2.43M
ENDP
39
DELISTED
Endo International plc
ENDP
$5.23M 0.26%
75,543
+27,767
+58% +$2.22M
EBAY icon
40
eBay
EBAY
$50.4B
$5.22M 0.26%
213,437
+183,015
+602% +$4.92M
BIG
41
DELISTED
Big Lots, Inc.
BIG
$5.16M 0.25%
107,639
-16,577
-13% -$738K
VRTX icon
42
Vertex Pharmaceuticals
VRTX
$122B
$5.12M 0.25%
49,171
+35,079
+249% +$4.51M
HZNP
43
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.12M 0.25%
258,106
+200,969
+352% +$6.35M
KSS icon
44
Kohl's
KSS
$2.21B
$5.1M 0.25%
110,033
+73,284
+199% +$4.12M
BLUE
45
DELISTED
bluebird bio
BLUE
$5M 0.25%
4,509
+1,893
+72% +$3.45M
CYH icon
46
Community Health Systems
CYH
$391M
$4.98M 0.24%
140,788
+87,427
+164% +$4.01M
MAT icon
47
Mattel
MAT
$4.42B
$4.91M 0.24%
233,194
+193,338
+485% +$4.52M
INCY icon
48
Incyte
INCY
$24.9B
$4.88M 0.24%
44,260
-38,018
-46% -$4.26M
AMZN icon
49
Amazon
AMZN
$2.53T
$4.72M 0.23%
184,420
+174,780
+1,813% +$4.42M
SWKS icon
50
Skyworks Solutions
SWKS
$9.4B
$4.67M 0.23%
+55,418
New +$5.07M

Similar funds

GSA Capital Partners's Q3 2015 Portfolio in Review

As of Q3 2015, GSA Capital Partners held 2,297 positions worth $2.03B, down 22% from $2.6B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

GSA Capital Partners withdrew a net $189M in Q3 2015, closing 591 positions and reducing 638 holdings. Its most notable exit was Union Pacific, an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, GSA Capital Partners opened a new position in Baxter International worth $10.9M.

  • GSA Capital Partners's largest Q3 2015 buy was Baxter International: 331,369 shares worth $10.9M.
  • GSA Capital Partners added most to Macy's in Q3 2015, an estimated $17.2M increase.
  • GSA Capital Partners's biggest Q3 2015 reduction was Micron Technology, cutting an estimated $15.4M.
  • GSA Capital Partners fully exited Union Pacific in Q3 2015, selling an estimated $11.4M.
  • GSA Capital Partners's ten largest holdings make up 6.5% of its $2.03B portfolio in Q3 2015.
  • GSA Capital Partners opened 383 new positions and closed 591 in Q3 2015.
  • GSA Capital Partners's portfolio value fell 22% quarter-over-quarter to $2.03B.

Based on GSA Capital Partners's 13F filing for Q3 2015, filed 13 Nov 2015.